Surface Topography and Color Stability of Conventional, 3D Printed, and Milled Provisional Restorations.
Condition(s) studied
Investigational drug(s) / intervention(s)
To evaluate the color stability and surface roughness of implant supported provisional restorations fabricated using conventional technique, milling, and 3D printing in mandibular posterior region.: Subjects with single stage implant placement and early non-functional loading with implant supported provisional restorations fabricated using conventional technique, milling, and 3D printing.
Study summary
Patient attending the Outdoor Patient Department of the Department of Prosthodontics at Post Graduate Institute of Dental Sciences, Rohtak will be screened. The screening will include history, consent taking and clinical examination of the partially edentulous patients. Patients will be selected according to the inclusion and exclusion criteria. Single stage endosseous implants will be placed. Provisional restorations fabricated by conventional technique, milling, and 3D printing will constitute three groups, followed by evaluation of color stability and surface roughness after intraoral use.
Eligibility
Primary outcome measure(s)
- Surface roughness of implant supported provisional restorations fabricated using conventional technique, milling, and 3D printing. — 1 year 6 months
Surface roughness of provisional restorations will be measured using profilometer - Color stability of implant supported provisional restorations fabricated using conventional technique, milling, and 3D printing. — 1 year 6 months
Color stability of provisional restorations will be measured using spectrophotometer
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Post Graduate Institute of Dental Sciences | Rohtak | Haryana | Recruiting |
More Postgraduate Institute of Dental Sciences Rohtak trials in India
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06946693 on ClinicalTrials.gov ↗ ← All trials in India